Alternate Health Corp. announced the appointment of Christopher Boling to the position of Chief Financial Officer, the appointment of Jim Griffiths to the position of Senior Vice President of Finance, the appointment of Michael Klipper to the role of Chief of Research and Product Development, and the issuances of common shares and incentive stock options. Christopher Boling was appointed as the company's Chief Financial Officer effective January 25, 2018.

He takes over from Jim Griffiths who has been appointed Senior Vice President Finance effective January 25, 2018. Mr. Griffiths continues to serve as a director of the company. Mr. Boling has over 20 years of experience in senior financial leadership roles for global public firms like Textron and Pirelli S.p.A. For the last 5 years, Mr. Boling has been working at the CFO level for high-growth technology companies in additive manufacturing and solar energy, where he was responsible for establishing U.S. operations, managing a $250 million credit facility, and preparing a public debt offering.

The company announced the appointment of Mr. Michael Klipper as Chief of Research and Product Development. Mr. Klipper is currently a director of the company. A formulary chemist, entrepreneur, author, and fundraiser, Mr. Klipper is the Co-Founder of Cannabinoid Science International Corp.

and a respected member of the International Cannabinoid Research Society.